STUDIES ASSESSING THE CLINICAL MEANINGFULNESS OF INSULIN DOSE IN TYPE 1 DIABETES
SRA and IDDP applications may request up to a total of $750,000 over a maximum of two years. - Wednesday November 05, 2025 (LOI)
Breakthrough T1D, USThis RFA is intended to solicit proposals investigating the effects of insulin dose and insulin dose reduction on acute and long-term T1D outcomes.
